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Abstract 
Intermittent Hypoxia Attenuates Ischemia-Reperfusion Injury 
Caitlin Patricia Jarrard, M.S.Kin. 
The University of Texas at Austin, 2020 
Supervisor: Sophie Lalande 
Brief periods of ischemia preceding an ischemia-reperfusion injury, known as ischemia 
preconditioning, attenuate the reduction in brachial artery endothelial function. It remains 
unknown whether brief bouts of systemic hypoxemia would similarly mitigate the blunted 
vasodilatory response induced by an ischemia-reperfusion injury. The purpose of this study was 
to determine whether intermittent hypoxia protects against an ischemia-reperfusion injury in 
young healthy adults. Sixteen healthy individuals, 9 men and 7 women (age: 23 ± 3 years, 
height: 175 ± 9 cm, body weight: 72.9 ± 13.4 kg), participated in the study. Brachial artery 
endothelial function was assessed by flow-mediated dilation before and after a 20-minute blood 
flow occlusion. Blood flow occlusion was preceded by either intermittent hypoxia (Hyp) or 
intermittent normoxia (Norm). Both visits were separated by a period of seven days. Women 
who had regular menstrual cycles were scheduled in the early follicular phase. Intermittent 
hypoxia was created by titrating nitrogen into a breathing system to achieve an arterial oxygen 
saturation of 90%. Intermittent hypoxia consisted of three 4-minute hypoxic cycles separated by 
4-minute normoxic cycles. Intermittent hypoxia resulted in a lower arterial oxygen saturation
(Hyp: 87 ± 3 vs. Norm: 99 ± 1%, p < 0.01), which was equivalent to a lower fraction of inspired 
oxygen (Hyp: 0.123 ± 0.013, Norm: 0.210 ± 0.003, p < 0.01). When preceded by intermittent 
normoxia, blood flow occlusion resulted in a blunted flow-mediated dilation (Norm: 7.1 ± 2.5 to 
vii 
4.0 ± 2.4%). In contrast, the reduction in flow-mediated dilation following blood flow occlusion 
was attenuated by prior exposure to intermittent hypoxia (Hyp: 6.4 ± 1.9 to 4.4 ± 2.3%, p = 
0.048). Exposure to intermittent hypoxia did not affect mean arterial blood pressure (Hyp: 96 ± 
10, Norm: 96 ± 8 mmHg, p = 0.90) but significantly increased heart rate (Hyp: 72 ± 7, Norm: 63 
± 7 bpm, p < 0.01). In conclusion, exposure to mild levels of intermittent hypoxia attenuates the 
reduction in flow-mediated dilation induced by blood flow occlusion in young healthy 
individuals. Thus, intermittent hypoxia represents a potential strategy to mitigate the effect of 
ischemia-reperfusion injury associated with ischemic cardiovascular events.  
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The leading cause of mortality in the developed world stems from cardiovascular disease, 
with ischemic heart disease being the most prevalent (CDC, 2019). Ischemic heart disease refers 
to an inadequate oxygen supply to the myocardium due to a narrowing or blockage of the 
coronary arteries caused by a build-up of plaque. Main treatments of ischemic heart disease 
consist of medications, lifestyle changes, and procedures such as coronary artery bypass grafting 
or percutaneous coronary interventions (NHLBI, 2020). While restoration of blood flow is 
necessary, the sudden return of blood flow also paradoxically causes damage to the endothelial 
cells lining the coronary arteries that contribute to the control of vascular tone. Thus, both the 
ischemia and the restoration of blood flow to tissues cause damages to the endothelial cells, a 
phenomenon commonly referred to as ischemia-reperfusion injury (Kharbanda et al., 2001). 
 
Once reperfusion occurs, the oxygen influx contributes to the creation of reactive oxygen 
species (ROS) (Kalogeris et al., 2012). Reactive oxygen species occur as a byproduct of 
mitochondrial oxidative phosphorylation resulting in excess ROS that can produced cell and 
tissue injury (Sies, 1986). ROS accelerate the inactivation of nitric oxide, and therefore reduce 
nitric oxide bioavailability (Cai & Harrison , 2000; Kalogeris et al., 2012). Nitric oxide is 
released from endothelial cells and causes relaxation of the vascular smooth muscles therefore a 
low bioavailability of nitric oxide attenuates vasodilation (Tiefenbacher et al., 1996). Thus, 
ischemia-reperfusion injury induces an impaired endothelium-dependent vasodilation. It is 
therefore important to identify strategies to mitigate the effect of ischemia-reperfusion injury 
associated with blood flow restoration. However, due to the difficulty to assess the endothelial 
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function of coronary arteries, the effect of an ischemia-reperfusion injury has to be assessed in 




Measures of brachial artery endothelial function act as a surrogate measure of coronary 
artery endothelial function (Anderson et al., 1995). Assessment of endothelial function of the 
brachial artery consists in measuring the dilation of the brachial artery induced by an increase in 
blood flow following a short period of occlusion, known as flow-mediated dilation. Briefly, this 
method consists in measuring the increase in brachial artery diameter following a 5-minute upper 
arm occlusion induced by inflating a blood pressure cuff to supra-systolic levels (Kharbanda et 
al., 2001). Flow-mediated dilation occurs when the vessel wall becomes exposed to a frictional 
force known as shear stress. Blood flow determines shear stress, a vector parallel to the 
longitudinal axis of the blood vessel (Niebauer & Cooke, 1996). The endothelial cells lining the 
blood vessel sense this increase in force, thus releasing a variety of vasodilators such as nitric 
oxide to allow the vascular smooth muscle to relax, consequently decreasing shear stress (Wilson 
et al., 2016). Therefore, when the blood vessel becomes reperfused following a period of 
occlusion, the increased blood flow causes an increase in shear stress which activates nitric oxide 
release. Thus, flow-mediated dilation represents endothelium-dependent vasodilation.  
 
The effect of an ischemia-reperfusion injury can be assessed by determining the effect of 
blood flow occlusion and reperfusion on brachial artery flow-mediated dilation. An ischemia-
reperfusion injury to the brachial artery occurs by occluding blood flow to the arm by inflating a 
cuff to supra-systolic levels for a period of 20 minutes, which significantly decreases flow-
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mediated dilation. Flow-mediated dilation was blunted by 27% following an ischemia-
reperfusion injury  in young healthy, recreationally active individuals (Brunt et al., 2016). 
Similarly, flow-mediated dilation was decreased by 50% following an ischemia-reperfusion 
injury in young sedentary individuals (Figure 1) (Loukogeorgakis et al., 2007). In addition, 
others (Aboo Bakkar et al., 2018) demonstrated a reduction in flow-mediated dilation of 56% in 
fourteen physically inactive males. 
  
Figure 1. Flow-mediated dilation before and 15 minutes after ischemia-reperfusion injury 




Previous studies investigated different interventions to diminish impairment in 
endothelial function following an ischemia-reperfusion injury. One of these interventions, 
ischemic preconditioning, consists in a few short bouts of ischemia induced by occluding blood 
flow to the arm by inflating a cuff to supra-systolic levels prior to the ischemia-reperfusion 
injury. Ischemic preconditioning largely attenuates the reduction in flow-mediated dilation 
induced by ischemia-reperfusion injury. Indeed, three 5-minute cycles of alternating ischemia 
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and reperfusion lessened the attenuation in flow-mediated dilation to 4 - 17%  in healthy 
volunteers (Kharbanda et al., 2001; Loukogeorgakis et al., 2007). Kharbanda et al. (2001) 
preconditioned the vessel three times for 5 minutes at a cuff inflation of 200 mmHg 5-minutes 
prior to inducing an ischemia-reperfusion injury. Flow-mediated dilation of the radial artery was 
attenuated by 17% in the preconditioning trial compared to the reduction of 54% without 
ischemic preconditioning (Figure 2). Using a similar protocol on the contralateral arm, 
Loukogeorgakis et al. (2007) reported a 4% reduction in brachial artery flow-mediated dilation 











Figure 2. Dilation of the radial artery at baseline, after ischemia-reperfusion (IR) alone, and after 
IR preceded by ischemic preconditioning (IR and IPC) (Kharbanda et al., 2001). Used with 
permission from Wolters Kluwer.  
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Ischemic preconditioning generates ROS allowing for a cardioprotective effect. 
Excessive ROS formation during ischemia can contribute to the reperfusion injury, but ROS are 
important in triggering the cardioprotective mechanism in preconditioning (Pagliaro & Penna, 
2015). This protective effect stems from the opening of mitochondrial ATP-sensitive potassium 
channels which have been shown to protect against ischemia-reperfusion through allowing an 
influx of K+ into the matrix, causing an increase in ROS (Andrukhiv et al., 2006; 
Loukogeorgakiset al., 2007). Ischemic preconditioning also inhibits the opening of the 
mitochondrial permeability transition pores which contributes greatly to the cardioprotection of 
the vessel (Andrukhiv et al., 2006; Garlid et al., 2009; Hausenloy et al., 2009). The closing of 
these vessels avoids ROS-induced ROS release and redox stress which can cause further damage 
to the vessel (Andrukhiv et al., 2006). 
 
Preconditioning through systemic hypoxia  
 
 
Since brief bouts of ischemia prevents the reduction in flow-mediated dilation induced by 
an ischemia-reperfusion injury, it is hypothesized that systemic hypoxia may also protect 
endothelial function against ischemia-reperfusion injury. Normal air contains an oxygen 
concentration of 20.9%. Breathing low levels of oxygen, induced by reducing the fraction of 
inspired oxygen, leads to systemic hypoxemia, a lower concentration of oxygen in the blood. In 
healthy adults, the net effect of systemic hypoxemia is skeletal muscle vasodilation (Dinenno et 
al., 2003). Nitric oxide appears to be a major contributor to the compensatory dilator responses 
observed during hypoxia. Moreover, the nitrate-nitrite-nitric oxide pathway, operating in parallel 
to the classic L-arginine-nitric oxide synthase pathway to generate nitric oxide, is greatly 
enhanced under hypoxic conditions (Kim-Shapiro et al., 2006). Hypoxia increases nitric oxide 
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production through the activation of hypoxia-inducible factor-1 (HIF-1 α). HIF-1α stimulates the 
expression of inducible nitric oxide synthase (iNOS) which is directly responsible for increasing 
the bioavailability of nitric oxide, thus inducing vasodilation (Jung Frank et al., 2000; Wilson et 
al., 2016).  
 
Intermittent hypoxia consists in alternating short bouts of breathing hypoxic and 
normoxic air. Intermittent hypoxia protected against ischemia-reperfusion injury in animals. 
Chronic intermittent hypobaric hypoxia has been seen to protect against ischemia-reperfusion 
injury induced in the rat heart (Bu et al., 2015). Intermittent hypobaric hypoxia lasting 28 or 42 
days at an altitude of 3000 m protected the heart against injury in developing rats through the 
recovery of the left ventricle and diminished ultrastructural damage to the myocardium (Bu et al., 
2015). Intermittent hypoxia, consisting of 5 alternating bouts of 5-6 minutes of hypoxia at a 
fraction of inspired oxygen of 0.06 and normoxia, induced a cardioprotective effect in response 
to ischemia-reperfusion injury in mice (Caiet al., 2003). Indeed, infarct size was significantly 
reduced in hearts from mice exposed to this intermittent hypoxia protocol 24 hours before 
inducing an ischemia-reperfusion injury to the coronary arteries. It was conclude that hypoxic 
preconditioning acted as a protective mechanism due to the expression of HIF-1 (Cai et al., 
2003). Indeed, mice with the reduced HIF-1 protein showed no protective effect from 
intermittent hypoxia, suggesting that cardioprotection depends on HIF-1α expression (Cai et al., 
2003). In addition to increasing nitric oxide bioavailability, HfIF-1α regulates expression of 
genes involved in maintaining oxygen homeostasis in response to a change in concentration of 
oxygen, such as hypoxia, as well as shifting the metabolism to anaerobic metabolism (Yoon et 
al., 2006; Ziello et al., 2007). HIF-1α coordinates this shift by inducing glycolytic enzymes and 
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glucose transporters to allow the cells to produce energy in a hypoxic environment (Ziello et al., 
2007). Therefore, expression of HIF-1α prior to the ischemia-reperfusion injury protects the 
heart against damage caused by the ischemia and reperfusion. Intermittent hypoxia may therefore 
induce endothelial function protection via a mechanism distinct from the local protective 
response induced by brief ischemic preconditioning. 
 
In humans, the ability of intermittent hypoxia to prevent the reduction in flow-mediated 
dilation following ischemia-reperfusion injury remains unknown.  Therefore, the aim of this 
project was to determine whether exposure to intermittent hypoxia protects against ischemia-
reperfusion injury in young healthy adults.  We hypothesized that intermittent hypoxia will 
attenuate the reduction in flow-mediated dilation following ischemia-reperfusion injury in young 


















The leading cause of mortality in the developed world stems from cardiovascular disease, 
with 17.9 million individuals dying each year worldwide (CDC, 2019). One in every four deaths 
result from the most common form of cardiovascular disease, ischemic heart disease. 
Characteristics of ischemic heart disease include a narrowing of the coronary arteries due to a 
plaque build-up on the artery wall, causing an inadequate blood flow and damages to the 
endothelial cells lining the blood vessels. While the process of unblocking the coronary arteries 
allows an influx of oxygen to the previously ischemic area, the sudden restoration of blood flow 
simultaneously damages the endothelial cells, known as ischemia-reperfusion injury. This injury 
results from the excessive production and formation of reactive oxygen species during ischemia 
and reperfusion, which causes a reduction in the bioavailability of nitric oxide, thus reducing 
endothelium-dependent vasodilation (Kharbandaet al., 2001). 
 
Brachial artery endothelial function strongly correlates with coronary artery endothelial 
function (Takse et al. 1998). Therefore, measures of brachial endothelial function, such as flow-
mediated dilation, can act as a surrogate measure of coronary artery endothelial function 
(Anderson et al., 1995). Flow-mediated dilation, an indicator of nitric oxide-dependent 
endothelial function, represents the dilation of the brachial artery following increases in blood 
flow induced by a transient period of ischemia. An ischemia-reperfusion injury similar to that 
observed in the coronary arteries can be achieved by inflating a cuff on the arm for a period of 20 
minutes before rapidly deflating the cuff, which causes a sudden restoration of blood flow to the 
arm. Following an ischemia-reperfusion injury, decreases in flow-mediated dilation ranges 
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between 36% to 50% in sedentary and young healthy individuals respectively (DeVan et al., 
2011; Loukogeorgakis et al., 2007) 
 
Ischemic preconditioning, consisting in few short bouts of local ischemia induced by 
occluding blood flow to the arm, attenuates the reduction in flow-mediated dilation induced by 
ischemia-reperfusion injury, possibly due to the opening of the mitochondrial ATP-sensitive 
potassium channels and the inhibition of the opening of the mitochondrial permeability transition 
pores (Garlid et al., 2009; Kharbanda et al., 2001; Loukogeorgakis et al., 2007). These two 
mechanisms allow an influx of K+ into the matrix increasing ROS and avoiding ROS-induced 
ROS release and redox stress respectively (Andrukhiv et al., 2006). 
 
It was therefore hypothesized that exposure to systemic hypoxia may represent another 
strategy to prevent or attenuate ischemia-reperfusion injury. In healthy adults, the net effect of 
systemic hypoxemia is a skeletal muscle vasodilation mediated by a release of nitric oxide from 
the endothelium (Dinenno et al., 2003). Intermittent hypoxia consists of alternating between 
breathing short bouts of hypoxic air and normoxic air. Intermittent hypoxia increases nitric oxide 
production through the activation of HIF-1α, which is directly responsible for increasing the 
bioavailability of nitric oxide (Jung Frank et al., 2000). Notably, when mice heterozygous for a 
knockout allele at the locus encoding HIF-1α were exposed to intermittent hypoxia, cardiac 
protection was lost indicating that cardioprotection through intermittent hypoxia is reliant on the 
HIF-1α gene (Cai et al., 2003). Upon the activation of HIF-1α, nitric oxide increases in response, 
thus inducing vasodilation in the vessel (Wilson et al., 2016).   
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Whether intermittent hypoxia prevents the reduction in flow-mediated dilation following 
an ischemia-reperfusion injury in humans remains unknown. Therefore, the aim of this study was 
to determine whether intermittent hypoxia protects against ischemia-reperfusion injury in young 
healthy adults. We hypothesized that intermittent hypoxia would attenuate the reduction in flow-




Sixteen healthy individuals, 9 men and 7 women, participated in the study. Participants 
were excluded from the study if they had a history of cardiovascular disease, diabetes or lung 
disease, had a resting blood pressure over 130/80 mmHg, took medication affecting the 
cardiovascular system, were pregnant, or were smokers. Participants visited the Clinical Exercise 
Physiology Laboratory on two occasions. On one visit, participants were exposed to intermittent 
normoxia and on the other visit, the same participants were exposed to intermittent hypoxia. The 
visit order was randomized, and participants were blinded to the condition. On Visit 1 
(intermittent normoxia), endothelium-dependent vasodilation of the brachial artery was assessed 
by flow-mediated dilation before and 15 minutes after an ischemia-reperfusion injury caused by 
20 minutes of blood flow occlusion of the right arm (Figure 3). On Visit 2 (intermittent hypoxia), 
a 20-minute intermittent hypoxia protocol immediately preceded the ischemia-reperfusion injury, 
with measures of flow-mediated dilation taking place before intermittent hypoxia and 15 minutes 
after the ischemia-reperfusion injury. Intermittent hypoxia consisted of alternating short periods 
of breathing hypoxic and normoxic air through a breathing circuit. Participants avoided intense 
physical activity on the day prior to both visits and reported to the laboratory in the morning after 
fasting for at least 10 hours. In men and women using contraceptives, both visits were separated 
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by a period of seven days. One woman was not using contraceptives, therefore, both visits took 
place in the early follicular phase of the menstrual cycle.  
 
Figure 3. Study protocol. FMD: Flow-mediated dilation. H: intermittent hypoxia bout lasting 4 
minutes. N: normoxia bout lasting 4 minutes. Ischemia: blood flow occlusion lasting 20-minutes. 
Recovery: reperfusion of blood flow for 15 minutes. 
 
Flow-mediated dilation  
Participants first rested in a supine, dimly lit room, for 15 minutes. Brachial blood 
pressure and heart rate was measured three times following the 15 minutes of rest. Endothelium-
dependent vasodilation of the brachial artery was assessed by flow-mediated dilation before and 
15 minutes after the ischemia-reperfusion injury using a semi-automated ultrasound machine 
(UNEXEF-38G, UNEX Corp., Japan) equipped with a high-resolution linear-array transducer 
positioned over the brachial artery. Participants extended their arm 90 degrees away from their 
body at heart level. A high-resolution linear-array transducer was positioned 2-8 cm proximally 
to the antecubital fossa and a cuff was placed 0.5-2.0 cm distal to the antecubital fossa. 
Longitudinal images of baseline brachial artery diameters were recorded for an average of 90 
seconds, blood velocities were measured at an insonation angle of ˂60° for 30 seconds prior to 
forearm occlusion. Forearm occlusion was induced with a rapid cuff inflator to a supra-systolic 
pressure for 5 minutes. Beat-by-beat blood velocity and brachial artery diameters were recorded 
for approximately 90 seconds following cuff release. Measures of baseline diameter, peak 
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diameter and time to peak diameter were automatically calculated. Shear stress was estimated 
using shear rate, which was calculated by multiplying 8 by the quotient of blood flow velocity 




To induce ischemia-reperfusion injury, a blood pressure cuff placed on the upper arm was 
inflated to 250 mmHg for a period of 20 minutes before deflating the cuff to allow reperfusion of 




The intermittent hypoxia protocol consisted of three 4 minutes hypoxic cycles at an 
arterial oxygen saturation of 90% interspersed with 4 minutes normoxic cycles. Participants laid 
down during the entire breathing protocol, which lasted 20 minutes with a total of 12 minutes of 
hypoxic exposure. Hypoxic air was inhaled through a mask connected to a 2-way non-
rebreathing valve (Hans Rudolph, Inc, USA), which was connected to a 5-liter non-diffusing gas 
bag (Hans Rudolph, Inc, USA). The rebreathing bag was connected to a gas tank of compressed 
air. Air was made hypoxic by introducing nitrogen in the breathing circuit. The flow of nitrogen 
was controlled to achieve an arterial oxygen saturation of 90%, as measured by pulse oximetry. 
Intermittent normoxia consisted of the same protocol but without adding nitrogen to the 






Arterial oxygen saturation was continuously monitored and recorded by pulse oximetry 
(NOVA, Finapres Medical Systems, Amsterdam, Netherlands) throughout the intermittent 
hypoxia and normoxia protocol. Resting hemodynamics were monitored during the intermittent 
hypoxia and normoxia protocol. An arterial waveform obtained by finger plethysmography from 
the middle finger of the left had was continuously recorded (NOVA, Finapres Medical Systems, 
Amsterdam, Netherlands). Brachial arterial blood pressure, heart rate, stroke volume, cardiac 
output and total peripheral resistance was derived from the arterial waveform, a method which 
has been validated against invasive measures (Wesseling et al., 1993). All data were recorded in 
LabChart (Powerlab, ADInstruments Inc., CO, USA) for later analysis. 
 
Pulmonary Gas Exchange 
 
Breath-by-breath measures of pulmonary gas exchange such as volume of oxygen and 
carbon dioxide, respiratory rate, tidal volume, and minute ventilation were determined from a 
pneumotachometer (Ultima Cardio2, MGC Diagnostics, MN, USA) throughout the intermittent 
hypoxia and normoxia protocol. The pneumotachometer was mounted between the mask and the 




A one-way repeated measures analysis of variance was used to evaluate whether the last 
minute of each cycle of intermittent hypoxia or intermittent normoxia triggered the same 
physiological responses. A one-way repeated measures analysis of variance was used to evaluate 
the effect of conditions (intermittent normoxia and intermittent hypoxia) on pulmonary gas 
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exchange, hemodynamics, and arterial oxygen saturation. A two-way repeated measures analysis 
of variance was used to evaluate the effect of time (pre vs. post-blood flow occlusion) and 
condition (intermittent normoxia vs. intermittent hypoxia) on measures of vasodilator function. 







Participants’ characteristics are shown in Table 1. Participants had a resting heart rate of 
58 ± 8 bpm and a resting systolic and diastolic blood pressure of 118 ± 11 and 66 ± 6 mmHg, 
respectively. There was no significant difference in any hemodynamic and pulmonary gas 
exchange variables across hypoxic cycles, therefore, an average value was calculated for each 
variable. Similarly, there was no difference in any variables across normoxic cycles, and average 
values were calculated for each variable. Intermittent hypoxia resulted in a lower fraction of 
inspired oxygen, which resulted in a lower arterial oxygen saturation in comparison to 
intermittent hypoxia (Table 2). There was no effect of intermittent hypoxia on oxygen 
consumption, respiratory rate, tidal volume, minute ventilation, and end-tidal CO2 (Table 2). 
Similarly, intermittent hypoxia did not significantly affect systolic, diastolic, mean arterial 
pressure, cardiac output, stroke volume, and total peripheral resistance. However, intermittent 





Table 1. Participants’ characteristics 
    




175 ± 9 
 
Weight (kg)  
 




23.7 ± 2.7 
 
Table 2. Hemodynamic and pulmonary gas exchange variables during intermittent hypoxia and 
intermittent normoxia. 
  Normoxia Hypoxia 
Systolic Blood Pressure (mmHg) 121 ± 11 123 ± 11 
Diastolic Blood Pressure (mmHg) 74 ± 9 76 ± 10 
Mean Arterial Blood Pressure (mmHg) 89 ± 8 92 ± 9 
Heart Rate (bpm) 62 ± 7 71 ± 6 * 
Stroke Volume (ml) 87 ± 19 82 ± 17 
Arterial Oxygen Saturation (%) 99 ± 1 87 ± 3 * 
Cardiac Output (L/min) 5.3 ± 1.1 5.8 ± 1.1 
Total Peripheral Resistance (mmHg/L/min) 17.8 ± 3.6 16.8 ± 3.1 
Oxygen Consumption (ml/kg/min) 3.46 ± 1.30 2.45 ± 0.81 
Respiratory Rate (breaths/minute) 13 ± 4 13 ± 3 
Tidal Volume (ml) 632 ± 259 608 ± 191 
Minute Ventilation (L/min) 7.33 ± 2.50 7.17 ± 1.37 
End-Tidal Carbon Dioxide (mmHg) 37.1 ± 3.3 35.3 ± 3.4 
Fraction of Inspired Oxygen (%) 21.0 ± 0.3 12.3 ± 1.29 * 
*p < 0.05 between Hypoxia and Normoxia 
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When preceded by intermittent normoxia, blood flow occlusion resulted in a blunted 
flow-mediated dilation (Figure 4). In contrast, the reduction in flow mediated dilation following 
blood flow occlusion was attenuated by prior exposure to intermittent hypoxia (Figure 4). 
Brachial artery baseline and peak diameters were greater following blood flow occlusion during 
both intermittent normoxia and intermittent hypoxia (Table 3). However, the change in diameter 
and shear rate AUC were smaller following blood flow occlusion during intermittent normoxia 
and intermittent hypoxia (Table 3). Time to peak diameter was not affected by blood flow 












Figure 4. Vasodilation rate pre-and post-blood flow occlusion during intermittent normoxia 





Table 3. Vasodilator function pre- and post-blood flow occlusion. 
 
 Normoxia Hypoxia  
  Pre Post  Pre Post 
Baseline Diameter (mm) 3.94 ± 0.70 *  4.19 ± 0.83 3.98 ± 0.71 4.21 ± 0.81 
Peak Diameter (mm) 4.20 ± 0.68 * 4.34 ± 0.80 4.23 ± 0.73 4.39 ± 0.80 
Change in Diameter (mm)  0.27 ± 0.07 * 0.15 ± 0.08 0.25 ± 0.06 0.17 ± 0.08 
Time to Peak Diameter (s)  55 ± 12 52 ± 14 60 ± 11 55 ± 13 
Shear Rate (AUC) 13188 ± 10794 * 8157 ± 7084 13172 ± 11224 8741 ± 6388 
 






The aim of this research project was to determine whether exposure to intermittent 
hypoxia attenuates the reduction in flow-mediated induced by an ischemia-reperfusion injury in 
young healthy adults.  It was observed that exposure to mild levels of intermittent hypoxia 
attenuates the reduction in flow-mediated dilation induced by blood flow occlusion in young 
healthy individuals. During intermittent normoxia, blood flow occlusion induced a 43% 
reduction in flow-mediated dilation, which is similar to the previously reported reductions in 
flow-mediated dilation ranging between 27-50% induced by the same blood flow occlusion 
protocol in young individuals (Brunt et al., 2016; DeVan et al., 2011; Loukogeorgakis et al., 
2007). Following a short exposure to mild levels of intermittent hypoxia, blood flow occlusion 
induced a 32% reduction in flow-mediated dilation. Thus, intermittent hypoxia represents a 
potential strategy to mitigate the effect of ischemia-reperfusion injury.  
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Effect of ischemic preconditioning on flow-mediated dilation 
 
Previous studies reported that ischemic preconditioning mitigates the effects of an 
ischemia-reperfusion injury (Kharbanda et al., 2001; Loukogeorgakiset al., 2007). Ischemic 
preconditioning consists of brief bouts of cuff inflation prior to the 20 minute blood flow 
occlusion. Indeed, three 5-minute bouts of ischemic preconditioning significantly reduced the 
flow-mediated dilation by 17% in the radial artery compared to a 54% decrease no ischemic-
preconditioning at all (Kharbanda et al., 2001). Whereas three short bouts of ischemic 
preconditioning in the contralateral arm similarly blunted the decrease in flow-mediated dilation 
by 4%  in young healthy adults compared to 54% without ischemic preconditioning 
(Loukogeorgakis et al., 2007). Ischemic preconditioning opens up mitochondrial KATP channels 
and inhibits the opening of the mitochondrial permeability transition pores, which have been 
shown to protect against an ischemia-reperfusion injury (Gross & Auchampach, 1992). 
 
Effect of intermittent hypoxia on flow-mediated-dilation  
 
Few animal studies showed that intermittent hypoxia protects against ischemia-
reperfusion injury induced in the heart (Bu et al., 2015; Cai et al., 2003). Bu et al. (2015) found 
that chronic intermittent hypobaric hypoxia lasting 28 and 42 days, 5 hours each day, at an 
altitude of 3000 m protects the heart against an ischemia-reperfusion injury in developing rats, as 
seen through recovery of left ventricle function and diminished ultrastructural damage to the 
myocardium. A mechanism that seems necessary to the cardioprotective effect of hypoxia 
exposure is the hypoxia-inducible factor 1 alpha (HIF-1α). Intermittent hypoxia reduced infarct 
size in mice (Cai et al., 2003). Reducing the expression of HIF-1α protein completely abolished 
the protective effects induced by intermittent hypoxia (Cai et al., 2003). These protective effects 
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stem from an increase in nitric oxide bioavailability, regulating genes involved in maintaining 
oxygen homeostasis, and shifting the metabolism to anaerobic metabolism (Yoon et al., 2006; 
Ziello et al., 2007). This shift occurs by HIF-1α regulating glycolytic enzymes and glucose 
transports allowing the cell to produce energy, despite the hypoxic environment (Ziello et al., 
2007). Expression of HIF-1α in the gene is essential for cardioprotection against an ischemia-
reperfusion injury. In humans, intermittent hypoxia reduced brachial flow-mediated dilation by 
32%, whereas normoxia decreased flow-mediated dilation by 43%. Although intermittent 




Wall shear stress directly correlates with flow-mediated dilation, indicating that the 
greater the shear stress, the higher the flow-mediated dilation (Gnasso et al., 2001). It was 
hypothesized that the reduction in shear rate area under the curve (AUC) following blood flow 
occlusion would be attenuated with intermittent hypoxia since hypoxia induces vasodilation. 
Breathing low amounts of oxygen allows a cascade of events starting with HIF-1α and ending 
with an increase in nitric oxide, inducing vasodilation (Wilson et al., 2016). The 20 minute blood 
flow occlusion decreased shear rate AUC, but the decrease in both the intermittent hypoxia and 
normoxia protocols were the same. This decrease in shear rate AUC is what is responsible for the 
lower flow-mediated dilation after blood flow occlusion because flow-mediated dilation and 
shear rate are directly correlated (Gnasso et al., 2001).  
 
The present study showed that a very short exposure to mild levels of intermittent 
hypoxia was sufficient to attenuate the reduction in brachial artery endothelial function following 
an ischemia-reperfusion injury. The intermittent hypoxia protocol consisted of three 4 minutes 
20 
hypoxic cycles at a targeted arterial oxygen saturation of 90%. Nonetheless, short exposure to 
mild levels of intermittent hypoxia attenuated the reduction in flow-mediated dilation induced by 
ischemia-reperfusion injury in young heathy individuals. It remains to be determined whether a 
longer hypoxic exposure duration to a lower arterial oxygen saturation results in a greater 
protective effect against ischemia-reperfusion injury. Moreover, administering the intermittent 
hypoxia protocol during the period of blood flow occlusion could also potentially attenuate the 
reduction in flow-mediated dilation. This technique, known as remote postconditioning, is 
defined as “an ischemic conditioning stimulus applied concurrently with an injurious ischemic 
episode but at a remote site” (Kerendi et al., 2005). Remote postconditioning in the leg has been 
seen to reduce flow-mediated dilation in the brachial artery by 12%, a similar degree of 
protection to ischemic preconditioning due to the protection from the activation of the 
mitochondria KATP channels (Loukogeorgakis et al., 2007). 
CONCLUSION 
Exposure to mild levels of intermittent hypoxia attenuated the reduction in flow-mediated 
dilation induced by blood flow occlusion in young healthy individuals. Thus, intermittent 
hypoxia represents a potentially safe, noninvasive strategy to mitigate the effect of ischemia-
reperfusion injury in patients with ischemic cardiovascular events.  
21 
REFERENCES 
 Aboo Bakkar, Z., Fulford, J., Gates, P. E., Jackman, S. R., Jones, A. M., Bond, B., & Bowtell, J. 
L. (2018). Prolonged forearm ischemia attenuates endothelium-dependent vasodilatation
and plasma nitric oxide metabolites in overweight middle-aged men. European Journal 
of Applied Physiology, 118(8), 1565–1572. https://doi.org/10.1007/s00421-018-3886-z 
Anderson, T. J., Uehata, A., Gerhard, M. D., Meredith, I. T., Knab, S., Delagrange, D., 
Lieberman, E. H., Ganz, P., Creager, M. A., & Yeung, A. C. (1995). Close relation of 
endothelial function in the human coronary and peripheral circulations. Journal of the 
American College of Cardiology, 26(5), 1235–1241. https://doi.org/10.1016/0735-
1097(95)00327-4 
Bertuglia, S. (2008). Intermittent hypoxia modulates nitric oxide-dependent vasodilation and 
capillary perfusion during ischemia-reperfusion-induced damage. American Journal of 
Physiology-Heart and Circulatory Physiology, 294(4), H1914–H1922. 
https://doi.org/10.1152/ajpheart.01371.2007 
Brunt, V. E., Jeckell, A. T., Ely, B. R., Howard, M. J., Thijssen, D. H. J., & Minson, C. T. 
(2016). Acute hot water immersion is protective against impaired vascular function 
following forearm ischemia-reperfusion in young healthy humans. American Journal of 
Physiology. Regulatory, Integrative and Comparative Physiology, 311(6), R1060–R1067. 
https://doi.org/10.1152/ajpregu.00301.2016 
Bu, H., Yang, C., Wang, M., Ma, H., Sun, H., & Zhang, Y. (2015). KATP channels and MPTP 
are involved in the cardioprotection bestowed by chronic intermittent hypobaric hypoxia 
in the developing rat. The Journal of Physiological Sciences, 65(4), 367–376. 
https://doi.org/10.1007/s12576-015-0376-5 
22 
Cai Hua, & Harrison David G. (2000). Endothelial Dysfunction in Cardiovascular Diseases: The 
Role of Oxidant Stress. Circulation Research, 87(10), 840–844. 
https://doi.org/10.1161/01.RES.87.10.840 
Cai Zheqing, Manalo Dominador J., Wei Guo, Rodriguez E. Rene, Fox-Talbot Karen, Lu 
Huasheng, Zweier Jay L., & Semenza Gregg L. (2003). Hearts From Rodents Exposed to 
Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion 
Injury. Circulation, 108(1), 79–85. 
https://doi.org/10.1161/01.CIR.0000078635.89229.8A 
CDC. (2019, December 9). Coronary Artery Disease | cdc.gov. Centers for Disease Control and
Prevention. https://www.cdc.gov/heartdisease/coronary_ad.htm
Chen, J., Ye, Z., Wang, X., Chang, J., Yang, M., Zhong, H., Hong, F., & Yang, S. (2018). Nitric 
oxide bioavailability dysfunction involves in atherosclerosis. Biomedicine & 
Pharmacotherapy, 97, 423–428. https://doi.org/10.1016/j.biopha.2017.10.122 
Das, D. K., Maulik, N., Sato, M., & Ray, P. S. (1999). Reactive oxygen species function as 
second messenger during ischemic preconditioning of heart. In D. K. Das (Ed.), Stress 
Adaptation, Prophylaxis and Treatment (pp. 59–67). Springer US. 
https://doi.org/10.1007/978-1-4615-5097-6_7 
DeVan, A. E., Umpierre, D., Harrison, M. L., Lin, H.-F., Tarumi, T., Renzi, C. P., Dhindsa, M., 
Hunter, S. D., & Tanaka, H. (2011). Endothelial ischemia-reperfusion injury in humans: 
Association with age and habitual exercise. American Journal of Physiology-Heart and 
Circulatory Physiology, 300(3), H813–H819. 
https://doi.org/10.1152/ajpheart.00845.2010 
23 
Dinenno, F. A., Joyner, M. J., & Halliwill, J. R. (2003). Failure of systemic hypoxia to blunt α-
adrenergic vasoconstriction in the human forearm. The Journal of Physiology, 549(Pt 3), 
985–994. https://doi.org/10.1113/jphysiol.2003.042507 
Engelland, R. E., Hemingway, H. W., Tomasco, O. G., Olivencia‐Yurvati, A. H., & Romero, S. 
A. (2020). Acute lower leg hot water immersion protects macrovascular dilator function
following ischaemia–reperfusion injury in humans. Experimental Physiology, 105(2), 
302–311. https://doi.org/10.1113/EP088154 
Garlid, A. O., Jaburek, M., Jacobs, J. P., & Garlid, K. D. (2013). Mitochondrial reactive oxygen 
species: Which ROS signals cardioprotection? American Journal of Physiology - Heart 
and Circulatory Physiology, 305(7), H960–H968. 
https://doi.org/10.1152/ajpheart.00858.2012 
Garlid, K. D., Costa, A. D. T., Quinlan, C. L., Pierre, S. V., & Santos, P. D. (2009). 
Cardioprotective Signaling to Mitochondria. Journal of Molecular and Cellular 
Cardiology, 46(6), 858–866. https://doi.org/10.1016/j.yjmcc.2008.11.019 
Gnasso, A., Carallo, C., Irace, C., De Franceschi, M. S., Mattioli, P. L., Motti, C., & Cortese, C. 
(2001). Association between wall shear stress and flow-mediated vasodilation in healthy 
men. Atherosclerosis, 156(1), 171–176. https://doi.org/10.1016/S0021-9150(00)00617-1 
Green Daniel J., Dawson Ellen A., Groenewoud Hans M.M., Jones Helen, & Thijssen Dick H.J. 
(2014). Is Flow-Mediated Dilation Nitric Oxide Mediated? Hypertension, 63(2), 376–
382. https://doi.org/10.1161/HYPERTENSIONAHA.113.02044
Gross G J, & Auchampach J A. (1992). Blockade of ATP-sensitive potassium channels prevents 
myocardial preconditioning in dogs. Circulation Research, 70(2), 223–233. 
https://doi.org/10.1161/01.RES.70.2.223 
24 
Jung Frank, Palmer Lisa A., Zhou Nan, & Johns Roger A. (2000). Hypoxic Regulation of 
Inducible Nitric Oxide Synthase via Hypoxia Inducible Factor-1 in Cardiac Myocytes. 
Circulation Research, 86(3), 319–325. https://doi.org/10.1161/01.RES.86.3.319 
Kalogeris, T., Baines, C. P., Krenz, M., & Korthuis, R. J. (2012). Cell Biology of 
Ischemia/Reperfusion Injury. International Review of Cell and Molecular Biology, 298, 
229–317. https://doi.org/10.1016/B978-0-12-394309-5.00006-7 
Kerendi, F., Kin, H., Halkos, M. E., Jiang, R., Zatta, A. J., Zhao, Z.-Q., Guyton, R. A., & Vinten-
Johansen, J. (2005). Remote postconditioning. Brief renal ischemia and reperfusion 
applied before coronary artery reperfusion reduces myocardial infarct size via 
endogenous activation of adenosine receptors. Basic Research in Cardiology, 100(5), 
404–412. https://doi.org/10.1007/s00395-005-0539-2 
Kharbanda Rajesh K., Peters Mark, Walton Benjamin, Kattenhorn Mia, Mullen Michael, Klein 
Nigel, Vallance Patrick, Deanfield John, & MacAllister Raymond. (2001). Ischemic 
Preconditioning Prevents Endothelial Injury and Systemic Neutrophil Activation During 
Ischemia-Reperfusion in Humans In Vivo. Circulation, 103(12), 1624–1630. 
https://doi.org/10.1161/01.CIR.103.12.1624 
Kim-Shapiro, D. B., Schechter, A. N., & Gladwin, M. T. (2006). Unraveling the Reactions of 
Nitric Oxide, Nitrite, and Hemoglobin in Physiology and Therapeutics. Arteriosclerosis, 
Thrombosis, and Vascular Biology, 26(4), 697–705. 
https://doi.org/10.1161/01.ATV.0000204350.44226.9a 
Loukogeorgakis Stavros P., Williams Rupert, Panagiotidou Anna T., Kolvekar Shyamsunder K., 
Donald Ann, Cole Tim J., Yellon Derek M., Deanfield John E., & MacAllister Raymond 
J. (2007). Transient Limb Ischemia Induces Remote Preconditioning and Remote
25 
Postconditioning in Humans by a KATP Channel–Dependent Mechanism. Circulation, 
116(12), 1386–1395. https://doi.org/10.1161/CIRCULATIONAHA.106.653782 
Luscher, T. F., & Vanhoutte, P. M. (1990). The Endothelium. CRC Press. 
Niebauer, J., & Cooke, J. P. (1996). Cardiovascular effects of exercise: Role of endothelial shear 
stress. Journal of the American College of Cardiology, 28(7), 1652–1660. 
https://doi.org/10.1016/S0735-1097(96)00393-2 
Paszkowiak, J. J., & Dardik, A. (2003). Arterial Wall Shear Stress: Observations from the Bench 
to the Bedside. Vascular and Endovascular Surgery, 37(1), 47–57. 
https://doi.org/10.1177/153857440303700107 
Pierini, D., & Bryan, N. S. (2015). Nitric Oxide Availability as a Marker of Oxidative Stress. In 
D. Armstrong (Ed.), Advanced Protocols in Oxidative Stress III (pp. 63–71). Springer.
https://doi.org/10.1007/978-1-4939-1441-8_5 
Wilson, C., Lee, M. D., & McCarron, J. G. (2016). Acetylcholine released by endothelial cells 
facilitates flow‐mediated dilatation. The Journal of Physiology, 594(24), 7267–7307. 
https://doi.org/10.1113/JP272927 
Yoon, D., Pastore, Y. D., Divoky, V., Liu, E., Mlodnicka, A. E., Rainey, K., Ponka, P., Semenza, 
G. L., Schumacher, A., & Prchal, J. T. (2006). Hypoxia-inducible factor-1 deficiency
results in dysregulated erythropoiesis signaling and iron homeostasis in mouse 
development. The Journal of Biological Chemistry, 281(35), 25703–25711. 
https://doi.org/10.1074/jbc.M602329200 
Ziello, J. E., Jovin, I. S., & Huang, Y. (2007). Hypoxia-Inducible Factor (HIF)-1 Regulatory 
Pathway and its Potential for Therapeutic Intervention in Malignancy and Ischemia. The 
Yale Journal of Biology and Medicine, 80(2), 51–60. 
